Brief: Cvi Investments Inc Reports 8.3% Passive Stake In Advaxis As Of Jan 21
30/01/2020 15:13
Jan 30 (Reuters) -
* CVI INVESTMENTS INC REPORTS 8.3% PASSIVE STAKE IN ADVAXIS
AS OF
JAN 21 - SEC FILING
Source text - (http://bit.ly/2GDD5qa)
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors